全球多克隆抗体市场 – 行业趋势和 2029 年预测

全球多克隆抗体市场分析及规模

过去几年，制药和生物技术公司取得了长足的发展。研发活动的增加以及市场参与者参与各种增长战略在很大程度上促进了市场的增长。因此，预计这些增长决定因素将在预测期内大幅增长。

• 2021 年全球多克隆抗体市场价值为 9.9739 亿美元，预计到 2029 年将达到 15.5404 亿美元，2022-2029 年复合年增长率为 5.70%。由于特异性更高，“一抗”在预测期内占据多克隆抗体市场中最大的产品类型细分市场，从而导致研发活动中的采用率增加。Data Bridge 市场研究团队策划的市场报告包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

全球多克隆抗体市场定义

多克隆抗体由一组抗体组成，这些抗体代表人体对抗原的正常免疫反应。多克隆抗体的开发需要用选定的抗原对动物进行反复免疫。它们是不同 B 细胞谱系产生的抗体的混合物。这些抗体是一组对特定抗原作出反应并分离该抗原上不同表位的免疫球蛋白分子。抗体通常是通过给合适的哺乳动物接种病毒（如兔子、老鼠或山羊）来产生的。体型较大的哺乳动物通常更受欢迎，因为它们可以收集更多的血清。抗原被注射到哺乳动物体内，导致 B 细胞产生对该抗原具有特异性的免疫球蛋白 G (IgG)。

报告范围和市场细分

Polyclonal Antibodies Market Dynamics

This section deals with understanding the market drivers, opportunities, restraints and challenges. All of this is discussed in detail as below:

Drivers

• Growing Prevalence of Diseases

The global polyclonal antibody market is expected to be driven by an increase in the incidence of infectious diseases and a rise in cancer prevalence, especially across the under developing economies.

Furthermore, the expanding healthcare sector, increase in neurobiology and stem cell research, and the availability of technologically advanced products are also expected to fuel market growth. Moreover, the polyclonal antibodies are highly stable, tolerant of pH and buffer changes which also cushions the market’s growth within the forecasted period. The growing demand for therapeutics antibodies is also projected to bolster the market's growth.

Opportunities

• Growing Research and Development

Moreover, the increase in number of research and development activities across the globe by major pharmaceutical and biotechnology companies are estimated to generate lucrative opportunities for the market.

• Surging Growing Techniques

Additionally, to maintain their positions in the highly competitive market, the companies employ a variety of techniques. Industry leaders in the global polyclonal antibody market use a variety of methods, including partnerships, mergers and acquisitions and collaboration which will further offer numerous growth opportunities for the market.

Restraints/Challenges Global Polyclonal Antibodies Market

• Stringent Regulations

Stringent government regulations and less standard validation process of production are expected to obstruct market growth.

• Low Purity and High Cost

Also, the cost of research antibodies is very high. The factors such as  low purity and concentration levels of specific polyclonal antibodies are projected to challenge the polyclonal antibodies market in the forecast period of 2022-2029.

This polyclonal antibodies market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the polyclonal antibodies market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Post Covid-19 Impact on Polyclonal Antibodies Market

The polyclonal antibodies market was largely impacted by the outbreak of COVID-19. The coronavirus (COVID-19) epidemic and subsequent lockdowns in several nations throughout the world have had a financial impact on enterprises of all types. The private healthcare sector is one of the areas where the COVID-19 epidemic has had a big impact. The imposition of the lockdown and social distancing restrictions by the government to curb the COVID-19 pandemic outbreak, put a financial strain on the healthcare industry in a number of countries. It led to halt of various operations, impeded the production and supply and other negative effects such as stifling business growth, technology event cancellations, suspensions of new developments and has affected the overall production and sales, limiting the industry's expansion. As a result, the worldwide polyclonal antibody market is projected to be constrained by the COVID-19 pandemic throughout the forecast period.

With a gradual decrease in the disease, the restrictions are likely to relax and the various operations will continue, which will help the market witness a slight increment post COVID-19.

Global Polyclonal Antibodies Market Scope

The polyclonal antibodies market is segmented on the basis of product types and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Primary Antibody
• Secondary Antibody

On the basis of product types, the polyclonal antibodies market is segmented into primary antibody and secondary antibody. The primary antibody segment is registered to hold a dominant share in terms of revenue due to greater specificity which further results in increase adoption in research and development activities.

Application

• Academic Research
• Commercial

On the basis of application, the polyclonal antibodies market is bifurcated into academic research and commercial.

Polyclonal Antibodies Market Regional Analysis/Insights

对多克隆抗体市场进行了分析，并按上述国家、产品类型和应用提供了市场规模洞察和趋势。

多克隆抗体市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

北美在多克隆抗体市场占据主导地位，因为该地区持续进行着研发活动，且拥有大量领先企业。

由于癌症和其他疾病的发病率不断上升以及对治疗性抗体的需求不断增长，预计亚太地区将在 2022 年至 2029 年的预测期内出现显著增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

医疗保健基础设施增长安装基础和新技术渗透

多克隆抗体市场还为您提供每个国家/地区资本设备医疗支出增长、多克隆抗体市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对多克隆抗体市场的影响的详细市场分析。数据涵盖 2010-2020 年的历史时期。

竞争格局和多克隆抗体市场份额分析

多克隆抗体市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对多克隆抗体市场的关注有关。

多克隆抗体市场的一些主要参与者包括  

• Thermo Fisher Scientific Inc.，（美国）
• 默克集团（德国）
• Abcam plc（英国）
• BD（美国）
• Bio-Rad Laboratories Inc.，（美国）
• Cell Signaling Technology Inc.（美国）
• F. Hoffmann-La Roche Ltd.，（瑞士）
• 丹纳赫（美国）
• 安捷伦科技（美国）
• PerkinElmer Inc.，（美国）
• 龙沙（瑞士）
• 金斯瑞 (中国)
• BioLegend, Inc.（美国）
• Illumia Inc.，（美国）
• ImmonoPresice Antibodies Ltd（加拿大）
• 藤瑞比奥（瑞典）
• 耶拿分析仪器有限公司 (德国)
• Omega BioTek Inc.，（美国）
• Dovetail Genomics（美国）
• Atlas Antibodies（瑞典）

研究方法：全球多克隆抗体市场

数据收集和基准年分析是使用具有大样本量的数据收集模块进行的。市场数据使用市场统计和连贯模型进行分析和估计。市场份额分析和关键趋势分析也是市场报告中的主要成功因素。如需了解更多信息，请请求分析师致电或下拉询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，涉及数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请咨询我们的行业专家 https://www.databridgemarketresearch.com/zh/speak-to-analyst/?dbmr=global-polyclonal-antibodies-market

SKU-52658